Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Guidance for the diagnosis and treatment of hypolipidemia disorders
Cindy Bredefeld
, M. Mahmood Hussain
, Maurizio Averna
, Dennis D. Black
, Mitchell F. Brin
, John R. Burnett
, Sybil Charrière
, Charlotte Cuerq
, Nicholas O. Davidson
, Richard J. Deckelbaum
, Ira J. Goldberg
, Esther Granot
, Robert A. Hegele
, Shun Ishibashi
, Wahida Karmally
, Emile Levy
, Philippe Moulin
, Hiroaki Okazaki
, Pierre Poinsot
, Daniel J. Rader
Manabu Takahashi, Patrizia Tarugi, Maret G. Traber, Mathilde Di Filippo, Noel Peretti
Show 5 others
Show less
Research output
:
Contribution to journal
›
Review article
›
peer-review
61
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Guidance for the diagnosis and treatment of hypolipidemia disorders'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Abetalipoproteinemia
100%
Hypolipidemia
100%
Fat-soluble Vitamins
66%
Related Disorders
66%
Hypobetalipoproteinemia
66%
High Dose
33%
Clinical Management
33%
Molecular Mechanism
33%
Clinical Presentation
33%
Cholesterol
33%
Caregivers
33%
Treatment Regimen
33%
Triglycerides
33%
Monogenic
33%
Genetic Disease
33%
Genetic Basis
33%
Plasma Lipid Levels
33%
Malabsorption
33%
Preconception Counseling
33%
Appropriate Treatment
33%
Hypocholesterolemia
33%
Severe Complications
33%
Patient Agency
33%
Insurance Agency
33%
Chylomicron Retention Disease
33%
Physician Agency
33%
Medicine and Dentistry
Hypolipemia
100%
Abetalipoproteinemia
100%
Hypobetalipoproteinemia
66%
Drug Megadose
33%
Triacylglycerol
33%
Pathophysiology
33%
Counseling
33%
Lifespan
33%
Malabsorption
33%
Lipid
33%
Cholesterol
33%
Chylomicron Retention Disease
33%
Hypocholesterolemia
33%
Diseases
33%
Genetic Condition
33%
Genetics
33%
Pharmacology, Toxicology and Pharmaceutical Science
Hypolipemia
100%
Abetalipoproteinemia
100%
Hypobetalipoproteinemia
66%
Diseases
66%
Triacylglycerol
33%
Pathophysiology
33%
Hypocholesterolemia
33%
Malabsorption
33%
Chylomicron
33%
Lipid
33%
Cholesterol
33%
Biochemistry, Genetics and Molecular Biology
Abetalipoproteinemia
100%
Genetics
66%
Hypobetalipoproteinemia
66%
Lifespan
33%
Blood Lipids
33%
Drug Megadose
33%
Triglyceride
33%
Lipid Level
33%
Hypocholesterolemia
33%
Chylomicron Retention Disease
33%
Cholesterol
33%
Molecular Mechanism
33%